Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Government Mechanics

USASpending

The federal government's open database of every contract, grant, and award, a goldmine for tracking who gets paid.

Also known as: USASpending.gov, Federal Spending Data

What it is
USASpending.gov is the official public database of federal awards, obligations, and outlays. It records who received money, from which agency, and for what. It draws on FPDS and other systems for near-authoritative award data.
What it does
It lets investors verify contract awards, track obligation trends by vendor, and confirm which public company actually won federal dollars. This turns press-release noise into checkable data. Rising obligations to a named contractor can foreshadow revenue.
The evidence
Analysts cross-reference USASpending obligations against company disclosures to validate federal revenue exposure for primes and subs.
Best for
Federal-exposed names like LDOS, GD, LMT, LHX, HII.
Pairs well with
idiq-contract, sole-source-contract, ndaa
Use cautiously with
Data lags reporting and can misattribute subcontract flows; the named prime is not always the ultimate beneficiary.
Cautions
Obligations are not yet outlays, so booked-to-revenue timing varies widely.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo